Make your money go further for just 25p per day

CVS Group disappoints again, but is the sell-off overdone?

02/08/2018 · CVS Group (CVSG) 

CVS Group disappoints again, but is the sell-off overdone?
Having reassured with a more positive trading update in January, shares in the UK’s leading veterinary group took another beating this week after a disappointing trading update. Is it time to give up on this hitherto high-flying cash machine, or keep the faith?

CVS Group (AIM:CVSG) now operates a total of 482 veterinary surgeries - 458 in the UK, 21 in the Netherlands and 3 in the Republic of Ireland - an online dispensary, four diagnostic laboratories and seven pet crematoria. It’s therefore a substantial player in what remains a highly fragmented market.

- So, what ‘s gone wrong?

The latest trading update covered results for the financial year ending 30 June 2018.

Total Group revenue for the year was up 20.7% to £327m. CVS is a highly acquisitive business and much of that growth came from acquisitions, however, like-for-like growth was still 4.9%, although unfortunately this was lower than the 5.6% reported in the first half.

We highlighted the appeal of CVS in our previous Premium Research note here

- Animed growing strongly but acquisitions prove more challenging

As expected, the strong growth in sales of Animed Direct has continued. Animed Direct is an on-line…

Sign up and read the full article

Register to continue reading this article.

Get FREE access now

Already a member? Login

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE TODAY

Become a Champion Investor for as little as £3.20 per report or get a year's worth of money-making analysis for just £90.

SUBSCRIBE NOW

More on CVS Group

Veterinary group CVS is in need of treatment

29/01/2019 · News & Insights
Shares in the UK’s leading veterinary group have slipped further following yet another disappointing trading update.…

Follow the directors: who’s buying?

12/12/2018 · News & Insights
The last few weeks have seen plenty of director buying from small caps but blue-chip managers…

‘Champion Chatter’ - 9%+ yield on offer in this little lot..

27/09/2018 · News & Insights
Another big day of news from the world of AIM and small caps. The share price…

CVS Group disappoints again, but is the sell-off overdone?

02/08/2018 · News & Insights
Having reassured with a more positive trading update in January, shares in the UK’s leading veterinary…

Best of AIM shares 2017 - CVS Group: hero to villain - time to buy?

07/12/2017 · Company research

More from the News & Insights

AIM heroes, villains and an exciting IPO, at last

M&S and Royal Mail: Is it too late to turn things around?

22/05/2019 · Marks & Spencer · Ocado · Royal Mail

Scapa Group - Bonkers valuation of the week

21/05/2019 · Scapa Group